Spray composition with reduced dripping
Patent 6565832 Issued on May 20, 2003. Estimated Expiration Date: 
January 31, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 31, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesNasal spray compositions Nasal spray compositions exhibiting increased retention in the nasal cavity Aqueous-based pharmaceutical composition Aqueous suspension for nasal administration of loteprednol Patent #: 6368616 InventorsAssigneeApplicationNo. 494574 filed on 01/31/2000US Classes:424/45, Organic pressurized fluid424/78.04, Ophthalmic preparation424/434, Mucosal (e.g., nasal, etc.)514/853DECONGESTANTExaminersPrimary: Hartley, Michael G.Assistant: Haghighatian, M. Attorney, Agent or FirmInternational ClassesA61K 009/12A61K 009/08 AbstractAn aqueous-based sprayable composition comprises a therapeutic or palliative agent, water and a mixture of microcrystalline cellulose and alkali metal carboxyalkylcellulose. In one embodiment, the composition is a non-Newtonian nasal spray exhibiting a very rapid viscosity recovery upon removal of shear forces. | |
